Company intelligence / Profile preview

Health Economics Consulting Group

United States

Ownership: Private
Development stage: Other

Overview

Health Economics Consulting Group (HECG) was a strategic consulting firm specializing in health economics and outcomes research (HEOR) for the life sciences industry. Founded in 2004, the company provided expert services in economic modeling, cost-effectiveness analysis, and market access strategy to pharmaceutical, biotechnology, and medical device companies. HECG focused on demonstrating the clinical and economic value of new health technologies to support reimbursement and commercialization efforts. In 2009, the firm merged with Oxford Outcomes, which was subsequently acquired by the global clinical research organization ICON plc in 2011.

Industry: Consulting

Partnerships

Rapid Pathogen Screening

Beyond the preview

Go deeper on Health Economics Consulting Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Health Economics Consulting Group.

Explore the full profile